Developmental and vascular risk factors for Alzheimer's disease

被引:92
作者
Borenstein, AR
Wu, YG
Mortimer, JA
Gerard, DSB
McCormick, WC
Bowen, JD
McCurry, S
Larson, EB
机构
[1] Univ S Florida, Coll Publ Hlth, Dept Epidemiol & Biostat, Tampa, FL 33612 USA
[2] Vet Affairs Med Ctr, GRECC, Div Gerontol & Geriatr Med, Seattle, WA USA
[3] Univ Washington, Dept Med, Seattle, WA 98195 USA
[4] Univ Washington, Dept Neurol, Seattle, WA 98195 USA
[5] Univ Washington, Dept Psychosocial & Community Hlth, Seattle, WA 98195 USA
[6] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA
关键词
Alzheimer's disease; vascular; developmental; risk factors; apolipoprotein E; brain reserve capacity;
D O I
10.1016/j.neurobiolaging.2004.04.010
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
To investigate developmental and vascular risk factors for Alzheimer's disease (AD), we examined 90 incident cases of probable AD in a cohort of 1859 individuals followed prospectively for six years. The presence of the APOE-epsilon4 allele was the strongest risk factor, and with increasing survival age, the effect of epsilon4 diminished. Among epsilon4 positives, developmental risk factors such as smaller head circumference ( less than or equal to 54.4 cm) and having more than four children in the household at age 2-3 were independently associated with incident AD (hazard ratio (HR) = 2.6 (95% CI 1.04-6.3) and 3.3 (1.2-9.2), respectively). Among epsilon4 negatives, vascular risk factors were related to AD risk (self-reported diagnoses of transient ischemic attack and diabetes (HR = 5.1, 95% CI 1.7-15.5; HR 3.3,95% CI 1.4-8.1)). These findings indicate that clinical AD is a result of early life as well as later life risk factors, and that genetic predisposition to the disease may modify the constellation of predictors. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:325 / 334
页数:10
相关论文
共 72 条
[1]   Apolipoprotein E and β-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent [J].
Beffert, U ;
Cohn, JS ;
Petit-Turcotte, C ;
Tremblay, M ;
Aumont, N ;
Ramassamy, C ;
Davignon, J ;
Poirier, J .
BRAIN RESEARCH, 1999, 843 (1-2) :87-94
[2]   Education modifies the relation of AD pathology to level of cognitive function in older persons [J].
Bennett, DA ;
Wilson, RS ;
Schneider, JA ;
Evans, DA ;
de Leon, CFM ;
Arnold, SE ;
Barnes, LL ;
Bienias, JL .
NEUROLOGY, 2003, 60 (12) :1909-1915
[3]  
Blair J.R., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]
[4]  
BORENSTEIN GA, 2004, NEUROEPIDEMIOLOGY, P102
[5]  
BORENSTEIN GA, 2003, AM J EPIDEMIOL, V157, P1
[6]   APOE-ε4 count predicts age when prevalence of AD increases, then declines -: The Cache County Study [J].
Breitner, JCS ;
Wyse, BW ;
Anthony, JC ;
Welsh-Bohmer, KA ;
Steffens, DC ;
Norton, MC ;
Tschanz, JT ;
Plassman, BL ;
Meyer, MR ;
Skoog, I ;
Khachaturian, A .
NEUROLOGY, 1999, 53 (02) :321-331
[7]   Congestive heart failure and cognitive impairment in an older population [J].
Cacciatore, F ;
Abete, P ;
Ferrara, N ;
Calabrese, C ;
Napoli, C ;
Maggi, S ;
Varricchio, M ;
Rengo, F .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1998, 46 (11) :1343-1348
[8]  
Cameron N., 1978, HUMAN GROWTH, DOI [10.1007/978-1-4684-2622-9_3, DOI 10.1007/978-1-4684-2622-9_3]
[9]   Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins [J].
Carmelli, D ;
Swan, GE ;
Reed, T ;
Miller, B ;
Wolf, PA ;
Jarvik, GP ;
Schellenberg, GD .
NEUROLOGY, 1998, 50 (06) :1580-1585
[10]   Apolipoprotein E:: a major piece in the Alzheimer's disease puzzle [J].
Cedazo-Mínguez, A ;
Cowburn, RF .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2001, 5 (03) :254-266